世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000031623

痙縮治療の世界市場(2022-2026)

TechNavio

Global Spasticity Treatment Market 2022-2026

発刊日 2022/03/02

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000031623

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、世界の痙縮治療市場を分析します。

世界の痙縮治療市場は、予測期間中に約4.17 %のCAGRで推移し、2022年から2026年の間に11億1,000万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、慢性疾患と健康状態の発生率の増加、ドラッグデリバリーのための高度な技術の利用可能性、および理学療法の人気の高まりによって推進されています。さらに、慢性疾患や健康状態の発生率の増加は、市場の成長も後押しすると予想されます。

調査範囲

  • 市場セグメント
    ➣ タイプ別
      ◇ 薬物療法
      ◇ 理学療法
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

本調査では、神経刺激装置の登場が、今後数年間の痙縮治療市場の成長を促進する主要な理由の1つであると特定しています。また、ボツリヌス毒素やカンナビノイドの導入、痙縮に対する意識の高まりは、市場の大きな需要につながると考えられます。

Technavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • 痙縮治療の市場規模
  • 痙縮治療の市場予測
  • 痙縮治療市場の業界分析

Technavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な痙縮治療市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ Allergan Plc
    ➣ Alembic Pharmaceuticals Ltd.
    ➣ Amneal Pharmaceuticals Inc.
    ➣ Covis Pharma BV, Dr
    ➣ Reddys Laboratories Ltd.
    ➣ Endo International Plc
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Hikma Pharmaceuticals Plc
    ➣ Ipsen Pharma
    ➣ Jazz Pharmaceuticals Plc
    ➣ Mayne Pharma Group Ltd.
    ➣ Merz Pharma GmbH and Co. KGaA
    ➣ Pfizer Inc.
    ➣ Piramal Enterprises Ltd.
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ Unichem Laboratories Ltd.
    ➣ US WorldMeds
    ➣ Cadila Healthcare Ltd.
    ➣ Medtronic Plc, and
    ➣ JPN Pharma Pvt. Ltd.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Drug therapy - Market size and forecast 2021-2026
Exhibit 28: Chart on Drug therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Drug therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Drug therapy - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Drug therapy - Year-over-year growth 2021-2026 (%)
5.4 Physical therapy - Market size and forecast 2021-2026
Exhibit 32: Chart on Physical therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Physical therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Physical therapy - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Physical therapy - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Type
Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business

10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Alembic Pharmaceuticals Ltd.
Exhibit 85: Alembic Pharmaceuticals Ltd. - Overview
Exhibit 86: Alembic Pharmaceuticals Ltd. - Product / Service
Exhibit 87: Alembic Pharmaceuticals Ltd. - Key offerings
10.4 Cadila Healthcare Ltd.
Exhibit 88: Cadila Healthcare Ltd. - Overview
Exhibit 89: Cadila Healthcare Ltd. - Business segments
Exhibit 90: Cadila Healthcare Ltd. - Key news
Exhibit 91: Cadila Healthcare Ltd. - Key offerings
Exhibit 92: Cadila Healthcare Ltd. - Segment focus
10.5 Dr. Reddys Laboratories Ltd.
Exhibit 93: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 94: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 95: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 96: Dr. Reddys Laboratories Ltd. - Segment focus
10.6 Endo International Plc
Exhibit 97: Endo International Plc - Overview
Exhibit 98: Endo International Plc - Business segments
Exhibit 99: Endo International Plc - Key news
Exhibit 100: Endo International Plc - Key offerings
Exhibit 101: Endo International Plc - Segment focus
10.7 Hikma Pharmaceuticals Plc
Exhibit 102: Hikma Pharmaceuticals Plc - Overview
Exhibit 103: Hikma Pharmaceuticals Plc - Business segments
Exhibit 104: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 105: Hikma Pharmaceuticals Plc - Segment focus
10.8 Ipsen Pharma
Exhibit 106: Ipsen Pharma - Overview
Exhibit 107: Ipsen Pharma - Business segments
Exhibit 108: Ipsen Pharma - Key offerings
Exhibit 109: Ipsen Pharma - Segment focus
10.9 Mayne Pharma Group Ltd.
Exhibit 110: Mayne Pharma Group Ltd. - Overview
Exhibit 111: Mayne Pharma Group Ltd. - Business segments
Exhibit 112: Mayne Pharma Group Ltd. - Key news
Exhibit 113: Mayne Pharma Group Ltd. - Key offerings
Exhibit 114: Mayne Pharma Group Ltd. - Segment focus
10.10 Medtronic Plc
Exhibit 115: Medtronic Plc - Overview
Exhibit 116: Medtronic Plc - Business segments
Exhibit 117: Medtronic Plc - Key news
Exhibit 118: Medtronic Plc - Key offerings
Exhibit 119: Medtronic Plc - Segment focus
10.11 Merz Pharma GmbH and Co. KGaA
Exhibit 120: Merz Pharma GmbH and Co. KGaA - Overview
Exhibit 121: Merz Pharma GmbH and Co. KGaA - Product / Service
Exhibit 122: Merz Pharma GmbH and Co. KGaA - Key offerings
10.12 Pfizer Inc.
Exhibit 123: Pfizer Inc. - Overview
Exhibit 124: Pfizer Inc. - Business segments
Exhibit 125: Pfizer Inc. - Key news
Exhibit 126: Pfizer Inc. - Key offerings
Exhibit 127: Pfizer Inc. - Segment focus

11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 128: Inclusions checklist
Exhibit 129: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 130: Currency conversion rates for US$
11.4 Research methodology
Exhibit 131: Research methodology
Exhibit 132: Validation techniques employed for market sizing
Exhibit 133: Information sources
11.5 List of abbreviations
Exhibit 134: List of abbreviations

Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Drug therapy - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Drug therapy - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Drug therapy - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Drug therapy - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Physical therapy - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Physical therapy - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Physical therapy - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Physical therapy - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Alembic Pharmaceuticals Ltd. - Overview
Exhibits86: Alembic Pharmaceuticals Ltd. - Product / Service
Exhibits87: Alembic Pharmaceuticals Ltd. - Key offerings
Exhibits88: Cadila Healthcare Ltd. - Overview
Exhibits89: Cadila Healthcare Ltd. - Business segments
Exhibits90: Cadila Healthcare Ltd. - Key news
Exhibits91: Cadila Healthcare Ltd. - Key offerings
Exhibits92: Cadila Healthcare Ltd. - Segment focus
Exhibits93: Dr. Reddys Laboratories Ltd. - Overview
Exhibits94: Dr. Reddys Laboratories Ltd. - Business segments
Exhibits95: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibits96: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibits97: Endo International Plc - Overview
Exhibits98: Endo International Plc - Business segments
Exhibits99: Endo International Plc - Key news
Exhibits100: Endo International Plc - Key offerings
Exhibits101: Endo International Plc - Segment focus
Exhibits102: Hikma Pharmaceuticals Plc - Overview
Exhibits103: Hikma Pharmaceuticals Plc - Business segments
Exhibits104: Hikma Pharmaceuticals Plc - Key offerings
Exhibits105: Hikma Pharmaceuticals Plc - Segment focus
Exhibits106: Ipsen Pharma - Overview
Exhibits107: Ipsen Pharma - Business segments
Exhibits108: Ipsen Pharma - Key offerings
Exhibits109: Ipsen Pharma - Segment focus
Exhibits110: Mayne Pharma Group Ltd. - Overview
Exhibits111: Mayne Pharma Group Ltd. - Business segments
Exhibits112: Mayne Pharma Group Ltd. - Key news
Exhibits113: Mayne Pharma Group Ltd. - Key offerings
Exhibits114: Mayne Pharma Group Ltd. - Segment focus
Exhibits115: Medtronic Plc - Overview
Exhibits116: Medtronic Plc - Business segments
Exhibits117: Medtronic Plc - Key news
Exhibits118: Medtronic Plc - Key offerings
Exhibits119: Medtronic Plc - Segment focus
Exhibits120: Merz Pharma GmbH and Co. KGaA - Overview
Exhibits121: Merz Pharma GmbH and Co. KGaA - Product / Service
Exhibits122: Merz Pharma GmbH and Co. KGaA - Key offerings
Exhibits123: Pfizer Inc. - Overview
Exhibits124: Pfizer Inc. - Business segments
Exhibits125: Pfizer Inc. - Key news
Exhibits126: Pfizer Inc. - Key offerings
Exhibits127: Pfizer Inc. - Segment focus
Exhibits128: Inclusions checklist
Exhibits129: Exclusions checklist
Exhibits130: Currency conversion rates for US$
Exhibits131: Research methodology
Exhibits132: Validation techniques employed for market sizing
Exhibits133: Information sources
Exhibits134: List of abbreviations

この商品のレポートナンバー

0000031623

TOP